(14:05 GMT) Monte Rosa Therapeutics Price Target Raised to $35.00/Share From $30.00 by Guggenheim
Dow Jones Newswires
Monte Rosa Therapeutics Is Maintained at Buy by Guggenheim
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:GLUE
- Language
- English